NCT05998642
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05998642
Title Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Arthur J.E. Child Comprehensive Cancer Centre RECRUITING Calgary Alberta T2N 5G2 Canada Details
BCCA - Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences RECRUITING Hamilton Ontario L8V 5C2 Canada Details
Ottawa Hospital Research Institute RECRUITING Ottawa Ontario K1H 8L6 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
The Research Institute of the McGill University RECRUITING Montreal Quebec H4A 3J1 Canada Details
CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) RECRUITING Québec Quebec G1J 1Z4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field